INSIGHTS ON REGULATORY COMPLIANCE

• Our Approach To Regulatory Compliance In China

  Leverage proven regulatory expertise and local support to turn China’s rigorous API requirements into a clear, efficient pathway to market success.

• cGMP Vs GMP In Cleanrooms: Understanding The Differences That Matter

  Differentiating GMP from cGMP helps facility teams design cleanrooms that meet modern contamination controls, process flows, and regulatory standards.

• Practical USP <1665>/<665> Guide To E&L Risk Assessment

  A practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.

• The Strategic Value Of In-House Delumping For Homogeneous API Production

  API batch homogeneity supports efficient manufacturing. Controlled delumping improves powder flow and chargeability while maintaining particle size integrity and reducing GMP-scale risks.

• How Connected Bioanalytical Context Management Strengthens Bioanalytical Decision-Making

  9/4/2026

  Preserving data context across bioanalytical workflows improves decision-making, ensures complete traceability, speeds up study review cycles, and prepares datasets for advanced AI.

• Analytical Approaches For Quantifying Residual Host Cell DNA

  5/29/2025

  In this webinar, we’ll discuss the challenges, risks and considerations involved in developing and using in-house residual testing solutions, and the benefits of using commercial kits for residual DNA testing.

• Lessons In Building Connected Lab Operations Across Development And GMP

  9/30/2026

  Building connected operations across development and GMP environments removes bottlenecks and ensures data integrity. Explore practical insights to scale and standardize your lab workflows.

• Quality Over Checkbox Compliance: From QRM To Quality Maturity

  3/23/2026

  Quality maturity shifts asset management from compliance-focused to risk-based. Discover how performance-driven calibration and leading indicators create systems where quality outcomes become inevitable.

• Single-Use Systems And Drug Product Manufacturing Challenges

  9/24/2026

  EU GMP Annex 1 calls for contamination control across the full manufacturing process. Learn why filter integrity testing alone is not enough and how evaluating fluid paths can strengthen quality.